- The Financial Times reported, citing sources, that if the inflation data released in the coming weeks proves strong and market expectations for higher borrowing costs intensify, Federal Reserve Chair Waller will be prepared to raise interest rates at the September meeting.
- Natural gas is hard to exit from the US power system: domestic resources, pipeline networks, and flexibility form a triple moat
- The wave of resistance against AI data centers spreads to India, as Google (GOOGL.US) faces an environmental crisis with its $15-billion project
- CHOICE HOTELS INTERNATIONAL, INC. <CHH.N>: DEUTSCHE BANK RAISES TARGET PRICE TO $124 FROM $116
- HUBSPOT, INC. <HUBS.N>: STIFEL CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $200 FROM $275
- Coldcard hackers transfer 64 BTC and 200 ETH to cryptocurrency mixers
- LYELL IMMUNOPHARMA, INC. <LYEL.O>: STIFEL INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $36
- GH Research says H1 loss widens as R&D spending rises on GH001 clinical, technical development work
- Cogent Q2 FY26 net income turns to profit at USD 66.64 million; revenue falls 1.5% to USD 235.56 million vs Q1 FY26
- Saudi Arabia lowers September official selling prices for Asia to more than five-year lows, regional crude oil pricing influenced by Hormuz negotiations
- Avalo Therapeutics posts corporate deck spotlighting IL-1β inhibitor pipeline for hidradenitis suppurativa
- Safe Pro Group receives USD 780,000 Department of War prime contractor purchase order
- Keurig Dr Pepper Q2 FY26 GAAP diluted EPS drops 90% to $0.04; net sales rise 75.6% to $7.31 billion
- Unity surged more than 16% in pre-market US trading; the company's adjusted earnings per share for the second quarter were $0.28, and revenue reached $546.5 million, both exceeding market expectations.
- VIAVI SOLUTIONS INC. <VIAV.O>: STIFEL RAISES TARGET PRICE TO $65 FROM $60
- FLUTTER ENTERTAINMENT PLC <FLUT.N>: STIFEL CUTS TARGET PRICE TO $133 FROM $161
- ZIMMER BIOMET HOLDINGS, INC. <ZBH.N>: STIFEL RAISES TARGET PRICE TO $110 FROM $105
- EXELIXIS INC <EXEL.O>: STIFEL RAISES TARGET PRICE TO $51 FROM $47
- US Foods Q2 FY26 adjusted EBITDA climbs 10.2% to $604 million; net sales rise 4.5% to $10.53 billion
- Lincoln International Q2 FY26 GAAP net income turns to profit at $455,000; revenue rises 51% to $225.7 million
- Paramount Resources issues corporate presentation outlining plan to lift output above 100,000 boe/d by end-2027
- SUNCOR ENERGY INC (CANADA) <SU.TO>: RAYMOND JAMES RAISES TARGET PRICE TO C$109 FROM C$103
- Foghorn Therapeutics Q2 FY26 net loss narrows to $7.2 million; collaboration revenue rises to $16.1 million
- Monte Rosa activates Phase 2 MODeFIRe-1 trial of MRT-2359 plus apalutamide in metastatic prostate cancer
- TIC Solutions Q2 FY26 net loss widens to $13.34 million; revenue rises 86% to $584.35 million
- Howmet Q2 FY26 GAAP EPS rises 33% to $1.33; revenue climbs 24% to $2.55 billion
- Qnity CEO Jon Kemp to speak at Deutsche Bank Technology Conference fireside chat
- Marten Transport FY26 Q2 net income drops 25.7% to $5.3 million; revenue falls 2.8% to $223.54 million
- LEGALZOOM.COM, INC. <LZ.O>: WILLIAM BLAIR CUTS TO MARKET PERFORM RATING
- PROPEL HOLDINGS INC : RAYMOND JAMES RAISES TO STRONG BUY FROM OUTPERFORM; RAISES TARGET PRICE TO C$38 FROM C$31
- FrontView REIT Q2 FY26 net income swings to profit of $1.52 million; revenue rises 2.57% to $18.01 million
- US Stock Movement | Palo Alto Networks (PANW.US) dropped as much as 4% pre-market after its products sold in China faced cybersecurity review
- PUMP price tests channel top after 35% weekly gain
- US Stock Movement | Palo Alto Networks (PANW.US) fell as much as 4% in pre-market trading as its products in China face cybersecurity review
- Warner Bros. Discovery (WBD.US): The World Cup had a negative impact on the audience share and advertising spending in international markets in June and July.
- Marriott Vacations Q2 FY26 net income rises 11% to $77 million; contract sales increase 22% to $545 million
- Siili Solutions cuts 2026 revenue outlook to EUR 95-105 million
- Silver Storm drills 215 g/t silver equivalent over 11.9 m at La Parrilla Rosarios Zone in Mexico
- ATS Q1 FY2027 adjusted revenue falls 5.2% on project timing, lower GLP-1-related demand, transportation restructuring impacts, company says
- White Pearl Technology, Aixia CEOs to host Q&A on takeover offer Friday
- Precision BioSciences Q2 net loss widens to $32.65 million; revenue drops to no revenue
- BKV posts investor presentation on website
- Camino Minerals launches brokered private placement of up to C$5.04 million units at C$0.42 each
- Driven Brands Q2 FY26 net income from continuing operations more than doubled to $37.3 million; revenue rises 6.8% to $507.4 million
- Immunovant FY27 Q1 net loss widens 27% to $153.2 million; R&D expenses rise 40.9% to $142.6 million
- WASGAU turns to H1 FY26 net loss of EUR 735,000; revenue rises 1.39% to EUR 325.3 million
- CURALEAF HOLDINGS, INC. <CURA.TO>: ALLIANCE GLOBAL PARTNERS ADJUSTS TARGET PRICE TO C$21 FROM C$6.5 TO REFLECT 1-FOR-3 REVERSE STOCK SPLIT
- Tripadvisor Q2 FY26 net income drops 38% to USD 22.8 million; revenue falls 7% to USD 441.9 million
- Ironwood Q2 FY26 GAAP net income rises 117% to $51.29 million; revenue increases 33% to $113.04 million
- Peloton FY26 net income turns to profit at $63.2 million; revenue falls 3.04% to $2.45 billion
- Smith Douglas Homes Q2 FY26 EPS drops to $0.03; revenue rises 22% to $273 million
- Tecnoglass Q2 FY26 net income drops to $24.6 million; revenue rises 15.6% to $295.3 million
- Appian 2Q Loss/Shr 16c >APPN
- Tarsus Pharmaceuticals 2Q Rev $173.9M >TARS
- Zoetis Sees 2026 Adj EPS $6.15-Adj EPS $6.25 >ZTS
- Viridian Therapeutics 1Q Loss/Shr $69.72 >VRDN
- Zoetis Sees 2026 Rev $9.12B-$9.32B >ZTS
- Viridian Therapeutics 1Q Rev $284,000 >VRDN
- Tarsus Pharmaceuticals: Deal Also Includes Milestones Up to $350M Upon Potential Regulatory Approval and First Comml Sale >TARS
- Axcelis Q2 FY26 GAAP diluted EPS falls 23.47% to 0.75; revenue rises 10.61% to 215.2 million
- Papa John’s FY26 Q2 diluted EPS drops 14.29% to $0.24; revenue falls 8.8% to $482.4 million
- Unusual Machines Q2 FY26 operating loss widens to $7.8 million; revenue rises 687% YoY to $16.7 million
- Ongwe Minerals plans 5,000-meter diamond drill program at Nguni gold prospect in Namibia
- Ocugen Q2 FY26 net loss widens to $24.88 million; revenue rises to $1.49 million
- Insmed Q2 FY26 net loss narrows to $13.2 million; revenue rises 296% to $425.5 million
- Arbe Robotics names Assaf Pereg CFO, replacing Karine Pinto-Flomenboim
- Tarsus Pharmaceuticals: Deal Incluses Upfront Consideration of About $450M, Consisting of $270M in Cash and $180M in Tarsus Common Stk >TARS
- Open Text 4Q Adj EPS $1.23 >OTEX
- Aya Gold & Silver acquires Morocco exploration portfolio for MAD 10 million
- Appian Q2 FY26 GAAP net loss widens to $11.82 million; revenue rises 19% to $203.26 million
- Resolute Holdings FY26 Q2 net loss per share widens to $(1.53); non-GAAP fee-related EPS climbs to $0.69
- Artemis Gold Q2 2026 profit rises as Blackwater mine posts higher grades, recoveries and throughput, company says
- BlackSky Q2 FY26 net loss narrows to $20.8 million; revenue rises 50% YoY to $33.3 million
- Ono Pharma partners with Mediar Therapeutics on antibody drugs for fibro-inflammatory diseases
- Datadog Q2 FY26 net income swings to USD 44.56 million; revenue rises 36% year-over-year to USD 1.12 billion
- Sionna net loss widens 65.43% to $29.89 million in Q2 FY26
- Lifetime Brands Q2 FY26 swings to GAAP net income of $19.61 million; net sales rise 7.4% to $141.57 million
- Nexstar FY26 Q2 net income rises 24.2% to $113 million; net revenue climbs 62.2% to $1.66 billion
- BRIEF-Driven Brands Holdings Inc Q2 Revenue USD 507.4 Million
- Lantheus Q2 FY26 GAAP EPS slips 0.9% to $1.11; revenue rises 2.7% to $388.2 million
- SITIME CORPORATION <SITM.O>: NEEDHAM RAISES TARGET PRICE TO $900 FROM $850
- ConocoPhillips names Andy O’Brien CEO, succeeding Ryan Lance
- Avalo Q2 FY26 net loss widens to $36.4 million; R&D expense rises 66.1% to $23.4 million
- Vistance Networks Q2 FY26 GAAP income from continuing operations rises to $26.1 million; net sales slip 1.4% to $319.6 million
- CareCloud Backs 2026 EPS 20c-EPS 23c >CCLD
- Intellia Therapeutics 2Q Rev $7.66M >NTLA
- 10-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - Germany vs Other Nations
- 2-Yr Benchmark Govt Yields - U.S. vs Other Nations
- 10-Yr Benchmark Govt Yields - U.S. vs Other Nations
- Korro Bio 2Q Loss/Shr $1.07 >KRRO
- Korro Bio 2Q Loss $18.9M >KRRO
- Gogo 2Q Rev $222.8M >GOGO
- Aclaris Therapeutics 2Q Loss/Shr 15c >ACRS
- Aclaris Therapeutics 2Q Loss $21.5M >ACRS
- Viatris 2Q Loss/Shr 10c >VTRS
- Core Natural Resources 2Q EPS $2.51 >CNR
- Bob's Discount Furniture 2Q Rev $619.6M >BOBS
- Lincoln International 2Q EPS 1c >LCLN
- Lincoln International 2Q Loss $23M >LCLN
